VANCOUVER, July 26 /CNW/ - July 21st, 2010 Heart Force Medical Inc., a Vancouver-based company that has developed a non-invasive cardiac assessment, monitoring and screening device is pleased to announced the receipt of a Canadian Innovation Leader Certificate, presented by the Government of Canada on behalf of the National Research Council.
This certificate was presented on Thursday July 22nd in Vancouver by The Honourable Steven Fletcher, Minister of State for Democratic Reform and Member of Parliament for Charleswood-St. James-Assiniboia, on behalf of the Honourable Gary Goodyear, Minister of State (Science and Technology) and John R. McDougall, President, National Research Council Canada, to highlight Heart Force's success as an innovative Canadian firm that has successfully linked scientific research to commercialization, jobs and economic growth.
"Last year we received recognition at the provincial level with the award for "most promising pre-commercial technology" from the British Columbia Technology Industry Association." said Sandy Burns, Heart Force Medical Chief Technology Officer. "This year we are receiving national recognition as a 'Canadian Innovation Leader' with this certificate and it seems appropriate to receive the award from Minister Steven Fletcher, given his work in establishing the national framework for Cardio-Vascular Disease. The support of the National Research Council has been critical in getting Heart Force Medical Inc. to where it is today. We are a better company as a result of their encouragement, support and financial contributions over the years and we hope that the relationship continues as Heart Force Medical strives to reach its goals."
About Heart Force:
Heart Force Medical Inc. (HFM), a private company, has invented and has patents pending for the digital Ballistocardiograph (dBG(TM)). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). This movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM's proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.
SOURCE HEART FORCE MEDICAL INC.
For further information: For further information: visit www.heartforcemedical.com or contact: Geoff Houlton, President and CEO, email@example.com, Direct: 604 566-8202; Issa Nakhleh, CFO, firstname.lastname@example.org, Direct: 604 566-8206